General public knowledge, perceptions and practice towards pharmaceutical drug advertisements in the Western region of KSA
This study aims to examine general public knowledge and behavior toward pharmaceutical advertisements in the Western part of KSA. A cross sectional convenience sampling technique was used in this study. A total of 1445 valid questionnaires were received and analyzed using SPSS version 16 at alpha va...
Saved in:
Published in | Saudi pharmaceutical journal Vol. 22; no. 2; pp. 119 - 126 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Saudi Arabia
Elsevier B.V
01.04.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This study aims to examine general public knowledge and behavior toward pharmaceutical advertisements in the Western part of KSA. A cross sectional convenience sampling technique was used in this study. A total of 1445 valid questionnaires were received and analyzed using SPSS version 16 at alpha value of 0.05. Majority of respondents were aware of different types of drugs to be advertised and drug advertisements should seek approval from the health authorities. Television and Internet showed the highest effect on consumers. Almost half of the participants preferred an advertised drug over non-advertised one. Most of the respondents indicated that the quality of frequently advertised drugs is not better than those prescribed by the doctors. Majority of participants had positive beliefs toward advertised drugs concerning their role in education and spreading of awareness among the public. Pharmaceutical advertisements harm the doctor–patient relationship as evidenced by one-third of the investigated sample. Moreover, majority of the participants mentioned that they would consult another doctor or even change the current doctor if he/she refused to prescribe an advertised medication. Results of this study could be used to develop awareness programs for the general public and try to enforce the regulations and policies to protect the general public and patients from the business oriented pharmaceutical companies and drug suppliers. |
---|---|
ISSN: | 1319-0164 2213-7475 |
DOI: | 10.1016/j.jsps.2013.03.002 |